BOSTON--(BUSINESS WIRE)--Emulate, Inc. announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. Food and Drug Administration’s (FDA) Office of ...
Emulate Inc., a biotech company focused on developing “organ-on-a-chip” technology, closed an $82 million Series E round on Tuesday. This latest round is intended to formulate a massive investment in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback